Primary Prevention
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| inclisiran sodium 300 mg in | Novartis AG (NVS) |
Frequently asked questions
How many drugs are in development for Primary Prevention?
BioSniper tracks 1 drug in development for Primary Prevention across 1 company.
How many clinical trials target Primary Prevention?
There are 1 clinical trial targeting Primary Prevention tracked by BioSniper.
Deep-dive into Primary Prevention
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis